ECSP034863A - AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES - Google Patents
AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASESInfo
- Publication number
- ECSP034863A ECSP034863A ECSP034863A ECSP034863A EC SP034863 A ECSP034863 A EC SP034863A EC SP034863 A ECSP034863 A EC SP034863A EC SP034863 A ECSP034863 A EC SP034863A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- combination
- agent
- agonist
- polinergic
- Prior art date
Links
- 230000000414 obstructive effect Effects 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 abstract 2
- 229940122086 Adenosine A2a receptor agonist Drugs 0.000 abstract 1
- 239000002465 adenosine A2a receptor agonist Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una combinación de un agonista selectivo del receptor A2a de adenosina y un agente anticolinérgico para la administración simultánea, consecutiva o separada por vía de inhalación en el tratamiento de una enfermedad obstructiva de las vías aéreas u otra enfermedad inflamatoria, con la condición de que el agente anticolinérgico no sea una sal tiotropioThe present invention relates to a combination of a selective adenosine A2a receptor agonist and an anticholinergic agent for simultaneous, consecutive or separate administration by inhalation in the treatment of an obstructive airway disease or other inflammatory disease, with the condition that the anticholinergic agent is not a tiotropium salt
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29384201P | 2001-05-25 | 2001-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034863A true ECSP034863A (en) | 2004-01-28 |
Family
ID=34572599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034863 ECSP034863A (en) | 2001-05-25 | 2003-11-25 | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES |
Country Status (4)
| Country | Link |
|---|---|
| CR (1) | CR7162A (en) |
| EC (1) | ECSP034863A (en) |
| PY (1) | PY0212140A (en) |
| ZA (1) | ZA200308465B (en) |
-
2002
- 2002-05-24 PY PY200200212140A patent/PY0212140A/en unknown
-
2003
- 2003-10-30 ZA ZA200308465A patent/ZA200308465B/en unknown
- 2003-11-19 CR CR7162A patent/CR7162A/en not_active Application Discontinuation
- 2003-11-25 EC ECSP034863 patent/ECSP034863A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PY0212140A (en) | 2004-07-01 |
| ZA200308465B (en) | 2004-11-01 |
| CR7162A (en) | 2004-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0209986A (en) | A2a agonist in combination with an anticholinergic agent for the treatment of obstructive airway diseases | |
| CR7152A (en) | A PDE4 INHIBITOR AND A COMBINATION ANTI-POLINERGIC AGENT TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS. | |
| CO5550426A2 (en) | NOVEDOUS THERAPEUTIC METHOD | |
| BR0008039A (en) | Combinations of formoterol and a tiotropium salt | |
| BR0115910A (en) | Organic compounds | |
| MEP35308A (en) | COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF | |
| CY1108978T1 (en) | A combination of methylxanthine and steroids compounds to treat chronic respiratory illnesses | |
| CY1106430T1 (en) | MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG | |
| CR11341A (en) | COMBINATION THAT INCLUDES PURINE DERIVATIVES AND OTHER COMPOUNDS AND THE USE OF THEM FOR THE TREATMENT OF INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY ROAD DISEASES | |
| ECSP034863A (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES | |
| ECSP045132A (en) | PHARMACEUTICAL COMBINATION | |
| UY27308A1 (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLYNERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS | |
| UY27565A1 (en) | PHARMACEUTICAL COMBINATION | |
| BRPI0410374A (en) | pharmaceutical composition comprising valsartan | |
| Mokra et al. | Phosphodiesterase inhibitors: Potential role in the respiratory distress of neonates | |
| HN2002000128A (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS. | |
| ECSP034864A (en) | A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS | |
| UY27307A1 (en) | A PDE4 INHIBITOR AND AN ANTI-POLYNERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROUTES | |
| ECSP045142A (en) | PHARMACEUTICAL COMBINATION | |
| BR112021026291A2 (en) | Lemborexant to treat sleep problems | |
| DOP2002000514A (en) | PHARMACEUTICAL COMBINATION | |
| BR0313305A (en) | Analgesic agent for newborn or fetal individuals | |
| AR036030A1 (en) | COMBINATION OF INHALATION OF A SELECTIVE ANTAGONIST OF ADENOSINE A2A RECEIVER AND AN ANTICOLINERGIC AGENT, PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMBINATION, ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT AND INHALATION DEVICE THAT INCLUDES THE SAME | |
| JP2007126441A5 (en) | ||
| Shei et al. | The effect of inguinal block and rectal paracetamol on the emergence characteristics after desflurane anesthesia in children for herniotomy |